The prices of prescription branded drugs widely used by older Americans rose by an average of 15.5% in 2015, some 130 times above inflation, according to a new report.
The latest Rx Price Watch study shows the average annual cost for one brand name drug used on a chronic basis now exceeds $5,800, up from $1,800 in 2006.
"These incredibly high price increases are still occurring in the face of the intense public and congressional criticism"
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze